Regenerative Medical Technology Group delays quarterly 10-Q filing for quarter ended June 30, 2026
RMTG•Late quarterly filing notice filed
Regenerative Medical Technology Group filed a Form NT 10-Q, delaying its quarterly report for the period ended June 30, 2026.
The company cited an inability to compile all information for the financial statements and related disclosures without unreasonable effort or expense.
It expects to file the Form 10-Q within the five-calendar-day extension allowed under SEC Rule 12b-25.
The notice indicated no anticipated significant change in results of operations versus the year-earlier period.
The late-filing notice was signed Aug. 14, 2026.
